低分子量肝素在治疗心血管疾病中的应用

被引：2

作者：

王云

机构：

来源：

中日友好医院学报 | 1999年 / 06期

关键词：

低分子量肝素; 发生率; 心血管疾病; 不稳定型心绞痛; 术后再狭窄; 血小板因子;

D O I：

暂无

中图分类号：

R54 [心脏、血管（循环系）疾病];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：351 / 354

页数：4

共 10 条

[1] 单剂量低分子量肝素在血液透析抗凝中的应用附视频 [J].

朱兰英，吴永贵，毛海萍，安业浩，彭文兴，李欣，曾牡华，陈惠珍 .

中华肾脏病杂志, 1996, (01) :32-35

[2]

Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty: The FACT Study[J] . Jean-Marc Lablanche,Eugene P. McFadden,Nicolas Meneveau,Jean Rene Lusson,Bernard Bertrand,Jean-Philippe Metzger,Victor Legrand,Gilles Grollier,Carlos Macaya,Bernard de Bruyne,Alec Vahanian,Alain Grentzinger,Christiane Masquet,Jean-Eric Wolf,Gerard Tobelem,Sylvie Fontecave,Andre Vacheron,Pascal d’Azemar,Michel E. Bertrand.Circulation . 1997 (10)

[3]

Rationale for low–molecular weight heparin in coronary stenting[J] . James P. Zidar.American Heart Journal . 1997 (5)

[4] Long-term anticoagulation of outpatients with adverse events to oral anticoagulants using low-molecular-weight heparin [J].

Harenberg, J ;

Huhle, G ;

Piazolo, L ;

Giese, C ;

Heene, DL .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (02) :167-172

[5] Low-molecular-weight heparin during instability in coronary artery disease [J].

Wallentin, L ;

Ohlsson, J ;

Swahn, E ;

Karlsson, E ;

Lundin, L ;

Landgren, F ;

Saetre, H ;

Adren, B ;

Enghoff, E ;

Lundstrom, T ;

Hjalmarsson, A ;

Nordlander, R ;

Andren, B ;

Blomstrand, P ;

Venge, P ;

Siegbahn, A ;

Almroth, G ;

Johansson, C ;

Normark, A ;

Wiklund, K ;

Logander, E ;

Lindstrom, G ;

Svensson, E ;

Undeland, S ;

Neiger, K ;

Perers, G ;

Irving, P ;

Andersson, I ;

Hammarstrom, E ;

Bastani, H ;

Eng, E ;

Lundin, P ;

Rehnqvist, N ;

Ambrant, B ;

Oblack, P ;

Holmstrand, M ;

Ekdahl, S ;

Nyman, I ;

Pantzar, Y ;

Ahlberg, G ;

Hagstrom, L ;

Sundqvist, C ;

Pihl, E ;

Gustafsson, G ;

Larsson, L ;

Gustavsson, PE ;

Lofmark, R ;

Lundqvist, IB ;

Lundqvist, L ;

Angman, K .

LANCET, 1996, 347 (9001) :561-568

[6]

Contemporary stent designs: Technical considerations, complications, role of intravascular ultrasound, and anticoagulation therapy[J] . Jeffrey J. Popma,Alexandra J. Lansky,Shigenori Ito,Gary S. Mintz,Martin B. Leon.Progress in Cardiovascular Diseases . 1996 (2)

[7] Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after Streptokinase (and heparin) in acute myocardial infarction [J].

Glick, A ;

Kornowski, R ;

Michowich, Y ;

Koifman, B ;

Roth, A ;

Laniado, S ;

Keren, G .

AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (14) :1145-1148

[8]

Prospective, randomized, placebo-controlled, double-blind, multicenter study of exercise with enoxaparin pretreatment for stable-effort angina[J] . Masatoshi Fujita,Shigetake Sasayama,Kazuzo Kato,Shuji Takaori.American Heart Journal . 1995 (3)

[9] LOW-MOLECULAR-WEIGHT HEPARIN VERSUS REGULAR HEPARIN OR ASPIRIN IN THE TREATMENT OF UNSTABLE ANGINA AND SILENT ISCHEMIA [J].

GURFINKEL, EP ;

MANOS, EJ ;

MEJAIL, RI ;

CERDA, MA ;

DURONTO, EA ;

GARCIA, CN ;

DAROCA, AM ;

MAUTNER, B .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (02) :313-318

[10]

Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics[J] . Judith A. Berliner,Mohamad Navab,Alan M. Fogelman,Joy S. Frank,Linda L. Demer,Peter A. Edwards,Andrew D. Watson,Aldons J. Lusis.Circulation . 1995 (9)

← 1 →